Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome

Journal of General Virology

Volumn 77, Issue 3, 1996, Pages 501-509

  Le Roux, Frédérique ^a   Sergeant, Alain ^a   Corbo, Laura ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; RNA TRANSLATION; VIRUS GENE; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 0029920821     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-3-501     Document Type: Article

References (41)

1. ANGEL, P , IMAGAWA, M., CHIU, R., STEIN, B., IMBRA, R. J., RAHMSDORF, H. J., JONAT, C., HERRLICH, P. & KARIN, M. (1987). Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor Cell 49, 729-739.
2. ANGEL, P., HATTORI, K., SMEAL, T. & KARIN, M. (1988) The Jun protooncogene is positively autoregulated by its product, Jun/AP1. Cell 55, 875-885.
3. BUISSON, M., MANET, E., BIEMONT, M. C., GRUFFAT, H., DURAND, B. & SERGEANT, A. (1989). The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R. Journal of Virology 63, 5276-5284.
4. CHAVRIER, P., GRUFFAT, H , CHEVALLIER-GRÉCO, A., BUISSON, M. & SERGEANT, A (1989). The Epstein-Barr virus (EBV) early promoter contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities. Journal of Virology 63, 607-614.
5. CHEVALLIES-GRÉCO, A., MANET, E., CHAVRIER, P., MOSNIER, C., DAILLIE, J. & SERGEANT, A. (1986). Both Epstein-Barr virus (EBV) encoded transacting factors, EB1 and EB2. are required to activate transcription from an EBV early promoter. EMBO Journal 5, 3243-3249.
6. CHEVALLIER-GRECO, A., GRUFFAT, H , MANET, E., CALENDER, A. & SERGEANT, A. (1989). The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R. Journal of Virology 63, 615-623.
7. CHO, M.-S. & TRAN, V.-M. (1993). A concatenated form of Epstein-Barr viral DNA in lymphoblastoid cell lines induced by transfection with BZLF1. Virology 194, 838-842.
8. COUNTRYMAN, J. K., JENSON, H., GROGAN, E. & MILLER, G. (1989). A 2.7 kb rearranged DNA fragment from Epstein-Barr virus capable of disruption of latency. Cancer Cells 4, 517-523.
9. DAIBATA, M., HUMPHREYS, R. E. & SAIRENJI, T. (1992). Phosphorylation of the Epstein-Barr vims BZLF1 immediate-early gene product Zebra. Virology 188, 916-920.
10. FARRELL, P. J., ROWE, D. T., ROONEY, C. M. & KOUZARIDES, T. (1989). Epstein-Barr virus BZLF1 transactivator specifically binds to a consensus AP-1 site and is related to c-Fos. EMBO Journal 8, 127-132.
11. Lyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. Journal of Virology 69, 2998-3006.
12. FLEMINGTON, E. & SPECK, S. H. (1990a) Identification of phorbol ester response elements in the promoter of the Epstein-Barr virus putative lytic switch gene BZLF1. Journal of Virology 64, 1217-1226
13. FLEMINGTON, E. & SPECK, S. H. (1990b). Autoregulation of Epstein-Barr virus putative lytic cycle switch gene BZLF1. Journal of Virology 64, 1227-1232.
14. GIOT, J. F., MIKAELIAN, I., BUISSON, M., MANET, E., JOAB, I., NICOLAS, J. C. & SERGEANT, A. (1991). Transcriptional interference between the EBV transcription factors EB1 and R both DNA-binding and activation domains of EB1 are required. Nucleic Acids Research 19, 1251-1258.
15. GLISIN, V , CRKVENJAKOV, R. & BYUS, C. (1974). Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 13, 2633-2639.
16. GORMAN, C. M., MOFFAT, L. F. & HOWARD, B. H. (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Molecular and Cellular Biology 2, 1044-1051
17. GRUFFAT, H., MANET, E., RIGOLET, A. & SERGEANT, A. (1990). The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein. Nucleic Acids Research 18, 6835-6843.
18. GUTSCH, D. E , HOLLEY-GUTHRIE, E. A., ZHANG, Q., STEIN, B., BLANAR, M. A., BALDWIN, A. S. & KENNEY, S. C. (1994). The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-κB. Molecular and Cellular Biology 14, 1939-1948.
19. HARDWICK, J. M., LIEBERMAN, P. M. & HAYWARD, S. D. (1988). A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. Journal of Virology 62, 2274-2284.
20. HUNTER, T. & KARIN, M. (1992). The regulation of transcription by phosphorylation. Cell 70, 375-387.
21. ITO, Y., KAWANISHI, M., HARAYAMA, T. & TAKABAYASHI, S. (1981). Combined effect of the extracts from Croton tiglium, Euphorbia lathyris or Euphorbia tirucalli and n-butyrate on Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells. Cancer Letters 12, 175-180.
22. KENNEY, S., KAMINE, J., HOLLEY-GUTHRIE, E., LIN, J. C., MAR, E. C. & PAGANO, J. (1989). The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters. Journal of Virology 63, 1729-1736
23. KLEHR, D , SCHLAKE, T., MAASS, K. & BODE, J. (1992) Scaffold-attached regions (SAR elements) mediate transcriptional effects due to butyrate. Biochemistry 31, 3223-3229.
24. KOLMAN, J. L., TAYLOR, N., MARSHAK, D. R. & MILLER, G. (1993). Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation. Proceedings of the National Academy of Sciences, USA 90, 10115-10119.
25. LAUX, G., FREESE, U. K., FISCHER, R., POLACK, E., KOFLER, E. & BORNKAMM, G. W. (1988). TPA-inducible Epstein-Barr virus genes in Raji cells and their regulation. Virology 162, 503-507.
26. LIEBERMAN, P. M , HARDWICK, J. M & HAYWARD, S. D (1989). Responsiveness of the Epstein-Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions. Journal of Virology 63, 3040-3050.
27. LIEBOWITZ, D. & KIEFF, E. (1993). Epstein-Barr virus. In Virology. pp. 107-172. Edited by B. N. Fields & D. M. Knipe. New York: Raven Press.
28. MANET, E., GRUFFAT, H., TRESCOL-BIEMONT, M. C., MORENO, N., CHAMBARD, P , GIOT, J. F. & SERGEANT, A. (1989). Epstein-Barr virus bicistronic mRNA generated by facultative splicing code for two transcriptional trans-activators. EMBO Journal 8, 1819-1826.
29. MIKAELIAN, I., DROUET, E., MARECHAL, V., DENOYEL, G., NICOLAS, J. C. & SERGEANT, A. (1993). The DNA-binding domain of two bZIP transcription factors, the Epstein-Barr virus switch gene product EB1 and Jun, is a bipartite nuclear targeting sequence. Journal of Virologv 67, 734-742.
30. MONTALVO, E. A., COTTAM, M., HILL, S. & WANG, Y.-C. J. (1995). YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter. Journal of Virology 69, 4158-4165.
31. PRANG, N., WOLF, H & SCHWARZMANN, F. (1995). Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1. Journal of Virology 69, 2644-2648.
32. ROONEY, C. M., ROWE, D. T., RAGOT, T & FARRELL, P. J. (1989). The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. Journal of Virology 63, 3109-3116.
33. SCHEPERS, A., PICH, D. & HAMMERSCHMIDT, W. (1993). Transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. EMBO Journal 12, 3921-3929.
34. SCHWARZMANN, F., PRANG, N., REICHELT, B., RINKES, B., HAIST, S., MARSCHALL, M. & WOLF, H. (1994). Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus transactivator gene BZLF1. Journal of General Virology 75, 1999-2006.
35. SINCLAIR, A. J., BRIMMEL, M., SHANAHAN, F. & FARRELL, P. J. (1991). Pathways of activation of the Epstein-Barr virus productive cycle. Journal of Virology 65, 2237-2244.
36. SISTA, N. D., PAGANO, J. S., LIAO, W. & KENNEY, S (1993). Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection. Proceedings of the National Academy of Sciences, USA 90, 3894-3898.
37. SISTA, N. D., BARRY, C., SAMPSON, K. & PAGANO, J. (1995). Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RARα and RXRα. Nucleic Acids Research 23, 1729-1736.
38. TAKADA, K., SHIMIZU, N., SAKUMA, S. & ONO, Y. (1986). Trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. Journal of Virology 57, 1016-1022.
39. URIER, G., BUISSON, M., CHAMBARD, P. & SERGEANT, A (1989). The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites. EMBO Journal 8, 1447-1453.
40. ZHANG, Q., GUTSCH, D. & KENNEY, S. (1994). Functional and physical interaction between p53 and BZLF1. Implication for Epstein-Barr virus latency. Molecular and Cellular Biology 14, 1929-1938.
41. ZUR HAUSEN, H., O'NEIL, E. J., FREESE, U. K. & HECHER, E. (1978). Persisting oncogenic herpes-virus induced by tumour promoter TPA. Nature 272, 373-375.